Search Results 1281-1290 of 72378 for Molecule
Prior clinical experience with CD38-targeting antibodies, including daratumumab, establish this molecule as an important therapeutic target in multiple myeloma.
D. vasmatzis.george@mayo.edu; Assistant Professor of Laboratory Medicine and Pathology; Associate Professor of Molecular Medicine; Publications.
Basic and translational scientists with expertise in cell, molecular or physiological science and interest in understanding the basic mechanisms of the stated ...
Ramirez-Alvarado's laboratory is in the early stages of studying the role of cofactors and accessory molecules ... Molecular Biology, 2016-2021.
to entering the study. 4. Received biologic (< 28 days), small molecule targeted therapies (< 5 half-life) or other anti-cancer therapy within 21 days of ...
Advances include using a radioactive tracer with molecular imaging to identify early biochemical changes linked to prostate cancer, and testing ...
Tindall has devoted his career to understanding the cellular and molecular mechanisms by which prostate cancers progress from androgen dependence to ...
Molecular characterization of arthrofibrotic pathways. Myofibroblasts are postulated to be the key effector cells in the arthrofibrotic cascade and may be ...
The researchers identified unique molecular and cellular changes in the ... The therapy also rapidly reduced interferon activity, a key signaling molecule ...
BS - Molecular Biology Grove City College. src="/-/media/kcms/gbs/research/images/. Clinical Studies. Learn about clinical trials that address specific ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.